Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

FDA Grants TM-400 Orphan Drug Designation

July 28, 2011 12:38 pm | News | Comments

The U.S. Food and Drug Administration (FDA) has granted TikoMed AB’s TM-400Orphan Drug Designation for the mobilization of stem cells prior to stem cell transplantation treatment.


Visionary Pharmaceuticals Secures Funding

July 28, 2011 12:34 pm | News | Comments

Visionary Pharmaceuticals, Inc., has raised seed round investments from a consortium of angel investors.


Researchers Trace Early Journey of Modulating Cells

July 28, 2011 12:31 pm | News | Comments

Key cells in the hippocampus are formed in the base of the brain late in fetal life and undertake a long journey before reaching their final destination in the center of the brain shortly after birth, according to researchers at the National Institutes of Health.


Flow Cytometry with $5 and a Cell Phone

July 28, 2011 12:24 pm | News | Comments

Researchers at the BioPhotonics Laboratory at the UCLA Henry Samueli School of Engineering and Applied Science have developed a compact, lightweight, and cost-effective optofluidic platform that integrates imaging cytometry and fluorescent microscopy and can be attached to a cell phone


Single Cell Cloning

July 28, 2011 12:09 pm | Product Releases | Comments

Solentim’s Cell Metric uses non-image based focusing to locate possible colonies by imaging the entire well.


Brooks Acquires Nexus for $79M

July 28, 2011 8:23 am | News | Comments

Brooks Automation, Inc. has completed the acquisition of Nexus Biosystems, Inc., a California-based global market leader in life science automated compound and sample management solutions for $79 million.


Gas Chromatography/Mass Spectrometer

July 28, 2011 8:19 am | Product Releases | Comments

PerkinElmer, Inc. launched its Clarus SQ 8 Gas Chromatography/Mass Spectrometer. The Clarus SQ 8 provides extreme sensitivity to analyze samples accurately, with an 800:1 signal-to-noise specification.


Gene Design Software

July 28, 2011 8:11 am | Product Releases | Comments

DNA2.0 announced that the first collection of biological building blocks characterized by the BIOFAB International Open Facility Advancing Biotechnology are now available for use in the design and assembly of genes within DNA2.0’s Gene Designer software.


AstraZeneca Profits Level at $2.1B

July 28, 2011 8:00 am | News | Comments

AstraZeneca PLC reported more or less unchanged profits for the second quarter as it weathered a hit to sales revenue from generic competition. AstraZeneca reported a net profit for the period of $2.11 billion, up 0.3 percent from a year earlier.


Cornerstone Publishes CPI-613 Data

July 28, 2011 7:57 am | News | Comments

Cornerstone Pharmaceuticals, Inc. has published a paper describing the selective inhibition of cancer cell energy metabolism by its lipoate derivative compound, CPI-613.


FDA Claims Cetero Falsified Documents

July 28, 2011 7:46 am | News | Comments

The FDA is notifying pharmaceutical companies that bioanalytical studies conducted by Cetero Research, Houston, Texas between April 2005 and June 2010 in support of marketing applications may need to be repeated or confirmed.


Sanofi Q2 Earning Plummet

July 28, 2011 7:36 am | News | Comments

Sanofi saw its earnings slump 41% in the second quarter from a year earlier as growing competition from generic alternatives ate into sales of its more expensive drugs and offset gains from the recent acquisition of U.S. biotechnology firm Genzyme.


Profits Off 3% for BMS

July 28, 2011 7:25 am | by Linda A. Johnson | News | Comments

Drugmaker Bristol-Myers Squibb Co. said that its second-quarter profit fell nearly 3 percent due to higher taxes and increased costs for production, marketing and administration. Those were partly offset by a 14 percent jump in sales.


Bayer Profits Surge 40%

July 28, 2011 7:23 am | News | Comments

Pharmaceutical and chemical company Bayer AG says strong growth in the crop science division helped second-quarter profits rise more than 40 percent. Bayer reported net profits of €747 million for the period.


Combining Carbon Nanotubes With Proteins

July 27, 2011 12:26 pm | News | Comments

University of Pennsylvania  researchers have helped develop a nanotech device that combines carbon nanotubes with olfactory receptor proteins, the cell components in the nose that detect odors.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.